Prof. Dr. Björn Corzilius is a University Professor (W2) of Physical Chemistry at the University of Rostock, Germany, leading the Corzilius group. His research focuses on solid-state NMR spectroscopy, dynamic nuclear polarization (DNP), and applications in biomolecules and materials. He holds affiliations with the Leibniz Institute for Catalysis (LIKAT) and serves on multiple academic boards, including the transregional Collaborative Research Center TRR 386 and the journal Magnetic Resonance . Education: 1999: Studies of Chemistry, TU Darmstadt 2005: Diploma in Physical Chemistry (TU Darmstadt) 2008: Ph.D. in Physical Chemistry (TU Darmstadt) Research Interests: Solid-state NMR, DNP for sensitivity enhancement, paramagnetic metal ions, biomolecular dynamics, and method development. His work bridges theoretical and experimental approaches to advance structural and functional studies of complex systems like proteins, nucleic acids, and catalytic materials. Recent Article Trends: Focus on DNP applications in biomolecular interfaces, novel polarizing agents (e.g., Gd(III) complexes), and methodological advancements like serial polarization transfer and electron-decoupled DNP. Contributions span inorganic chemistry, materials science, and biophysical systems. Awards: Emmy Noether Fellowship (2012) Felix Bloch Lecture (2016) Regitze M. Vold Memorial Prize (2017) Best Ph.D. Supervision (2018) Grants & Labs: Principal Investigator of the Emmy Noether Group (2013–2019), now leading the DNP research team at the University of Rostock. Collaborates closely with LIKAT on catalytic and materials projects. His group actively develops open-access publishing platforms like Magnetic Resonance and hosts international conferences. Labs/Teams: The Corzilius group at the Institute of Chemistry (Rostock) specializes in NMR method development and applications. Associated with LIKAT for interdisciplinary catalysis research.
Sachdev Sidhu is a Research Professor and Entrepreneur in Residence at the University of Waterloo. His research focuses on synthetic antibodies, protein engineering, and biotechnological applications. He leads efforts in developing novel therapeutic antibodies, engineered protein systems, and molecular tools for biomedical research. His work spans cancer therapy, viral infection countermeasures, and regenerative medicine. Sidhu is also involved in translational research, bridging academic discoveries with commercial applications through entrepreneurial ventures. Key research interests include synthetic antibody libraries, CAR T-cell engineering, ubiquitin-based therapeutics, and phage display technologies. He has contributed to advancements in targeted therapies for glioblastoma, leukemia, and ocular diseases. His team develops innovative methods for protein design, such as engineered ubiquitin variants and modular antibody architectures. Publications highlight breakthroughs in antibody-based treatments, including synNotch CAR T cells for glioblastoma and neutralizing antibodies against SARS-CoV-2. His work integrates structural biology, molecular biology, and computational approaches to address complex biomedical challenges. Sidhu collaborates with industry partners to advance technologies into clinical and commercial settings.
Prof. Dr. Mathias Christmann is a faculty member at the Institute of Chemistry and Biochemistry, Freie Universität Berlin , leading the research group in Organic Chemistry . His work focuses on strategic and methodological challenges in synthetic chemistry, particularly in total synthesis, organocatalysis, and renewable resource transformations. Position: Professor Contact: mathias.christmann@fu-berlin.de Location: Takustr. 3, Room 24.16, 14195 Berlin Research Interests include: Natural product-inspired small molecule synthesis for biological pathway modulation Minimizing C-C bond formations through selective functionalization of terpene building blocks Organocatalytic and metal-catalyzed reactions in multistep sequences Flow chemistry applications for scalable and sustainable synthesis Biological evaluation of TRPC channel agonists/antagonists for cancer therapy Publication Trends highlight expertise in total synthesis of complex terpenoids, organocatalysis for stereocontrolled reactions, flow chemistry for late-stage transformations, and TRPC4/5 channel modulation in renal cancer studies. His group pioneers asymmetric desymmetrization , photo-oxidation protocols , and electrosynthesis methods with minimal reagent waste. Advisees include PhD candidates Jan-Hendrik Dickoff , Mayar Elbendary , Nadine Kreidt , Tobias Olbrisch , Kamar Shakeri , and Zhen Wang , focusing on terpene-based drug discovery and catalytic reaction design.
John E. Moses is a Professor at Cold Spring Harbor Laboratory (CSHL), where he leads the Moses Laboratory and serves as Faculty Head of the Mass Spectrometry Shared Resource for the Cancer Center. He is also a Cancer Center Member focusing on developing chemical tools for biological discovery, particularly in cancer research. Dr. Moses earned his D.Phil. in Synthetic Organic Chemistry from the University of Oxford in 2004. His academic journey includes positions as Professor of Organic Chemistry at La Trobe University (2017-2020), Level 6 Future Fellow at the Australian Research Council (2017-2021), and Reader & Associate Professor in Organic Chemistry at the University of Nottingham (2007-2017). Moses' research focuses on click chemistry, a powerful discovery method that uses robust chemical reactions to synthesize functional molecules. His lab specializes in developing and exploiting bond-forming click reactions for rapid synthesis of small functional molecules, including cancer drugs and chemical probes. They apply these molecular tools in multidisciplinary projects spanning biology and chemistry. His recent work has led to significant advances in click chemistry methodologies, including Diversity Oriented Clicking (DOC) and Phosphorus Fluoride Exchange (PFEx). These approaches have enabled the discovery of new cancer therapeutics and antibiotics effective against multidrug-resistant bacteria like MRSA. Dr. Moses has received numerous honors including the 2021 Organic Division Horizon Prize: Robert Robinson Award in Synthetic Organic Chemistry, Fellow of the Royal Society of Chemistry (2015), Thieme Chemistry Award (2011), and UK & ROI Lilly Award for Excellence in Organic Chemistry (2011). Through his work at CSHL, Moses mentors students and postdoctoral researchers while collaborating with biologists to develop Chemistry For Biology. His lab's innovative approaches have been supported by multiple grants, including those from the National Cancer Institute. The Moses Laboratory is at the forefront of click chemistry research, developing new methodologies while applying them to solve critical problems in cancer biology and antibiotic resistance.
Megan L. Matthews is an Assistant Professor in the Department of Chemistry at the University of Pennsylvania, School of Arts & Sciences, where she leads an active research group focused on chemical biology and enzymology. Her lab develops innovative chemical proteomics technologies to uncover novel enzyme cofactors and regulatory post-translational modifications, particularly those involving reactive electrophiles, which cannot be predicted from genomic sequences. B.S. in Chemistry, Miami University (2005) Ph.D. in Chemistry, The Pennsylvania State University (2011) Postdoctoral Fellow, The Scripps Research Institute (2012–2017) Her research centers on the concept of the 'electrophilome'—a largely unexplored half of the reactive proteome. By designing 'reverse-polarity' chemical probes, her group enables the discovery of functionally significant electrophilic modifications in proteins, especially those involved in cancer and Alzheimer’s disease. These discoveries open new avenues for therapeutic intervention through covalent targeting. The recent publications demonstrate a consistent focus on enzyme mechanisms, cofactor discovery, and chemical probe development. Her work spans from fundamental enzymology (e.g., halogenases, ribonucleotide reductases) to applied chemical biology (e.g., hydrazine probes, chemoproteomic profiling). The keywords across her publications highlight emerging themes in metalloenzymes, radical chemistry, and covalent proteome mapping. Her scientific contributions have been recognized through prestigious fellowships, including the Merck Helen Hay Whitney Postdoctoral Fellowship. She has published in top-tier journals such as Nature , Nature Chemical Biology , and Journal of the American Chemical Society . Dr. Matthews advises graduate students and postdoctoral researchers in her lab, fostering a collaborative and inclusive environment. Her lab emphasizes the importance of diverse perspectives in scientific discovery. She has secured research funding to support projects in probe development, target characterization, and disease mechanism studies, particularly in neurodegenerative diseases and cancer. The Matthews Lab is actively engaged in advancing reverse-polarity activity-based protein profiling (RP-ABPP) for in vivo applications and inhibitor screening. The group collaborates with experts in structural biology, spectroscopy, and disease modeling to translate basic discoveries into therapeutic insights.
Thomas Lectka is the Jean and Norman Scowe Professor in the Department of Chemistry at Johns Hopkins University, where he has been a faculty member since 1994. His research focuses on synthetic and physical organic chemistry, particularly in the area of organofluorine chemistry. PhD, Cornell University Postdoctoral Fellow, Heidelberg (Alexander von Humboldt Fellow) Postdoctoral Fellow, Harvard University (NIH Fellow) Dr. Lectka's research is centered on developing novel synthetic methods, especially for fluorination, and understanding the physical organic principles underlying reactivity. His work spans radical fluorination , catalytic asymmetric synthesis , and the design of fluorinated bioactive molecules . Using a combination of experimental and computational techniques, his lab investigates C-F bond formation , reaction mechanisms , and the biological applications of fluorinated compounds. His recent work, as reflected in publications from 2010 to 2024, shows a consistent trajectory in advancing fluorination methodologies, with increasing emphasis on site-selectivity , enantiocontrol , and biomedical relevance . Themes include the development of new reagents, mechanistic studies, and the synthesis of fluorinated natural product analogs and peptidomimetics. Dr. Lectka has received numerous honors and awards, including: ACS Arthur C. Cope Scholar (2024) ACS Maryland Chemist of the Year (2017) John Simon Guggenheim Memorial Fellowship Dreyfus Teacher-Scholar Award Sloan Fellowship NSF CAREER Award NIH First Award Eli Lilly Grantee Award He actively mentors graduate and undergraduate students in his research group, contributing to education and training in organic chemistry. His lab, The Lectka Group , is supported by grants from the NIH and NSF, enabling cutting-edge research in synthetic methodology and physical organic studies. The group fosters a collaborative environment focused on innovation in fluorine chemistry. The Lectka Group is an active research laboratory at Johns Hopkins University dedicated to pushing the boundaries of synthetic organic chemistry through the exploration of fluorine's unique properties. Current projects include site-selective radical fluorination and the synthesis of unusual fluorinated species, aiming to provide new tools for drug discovery and materials science.
Kay Severin is a full professor at the Laboratory of Supramolecular Chemistry (LCS) within École Polytechnique Fédérale de Lausanne (EPFL) , Switzerland. His research focuses on the design and reactivity of metal-ligand assemblies, including coordination cages, metalloligands, and supramolecular receptors. He has pioneered the use of metalloligands for constructing heterometallic architectures and developed systems for anion extraction and stimuli-responsive hydrogels. Key funder: Swiss National Science Foundation (FNS) Collaborative work with Rosario Scopelliti and Farzaneh Fadaei Tirani Research Interests: Severin's work spans supramolecular chemistry, organometallic synthesis, and functional materials. Recent projects include: Dynamic palladium-based hydrogels with anion-responsive crosslinks Gold(I)-driven nano-onion structures via π-stacking Triazene-derived ligands for Sandmeyer-type reactions Metalloligand assembly of Fe/Pd/Au heterotrimetallic cages Publication Trends: Over 300 publications since 1994, with recent emphasis on: Coordination-driven self-assembly (2024: 6 articles) Triazene and diazoolefin reactivity (2025: 4 articles) Metal-ligand interactions in nanogels and vesicles (2024-2025: 3 articles) Environmental applications in anion extraction (2025: 1 article)
Ying Ge is a Professor at the University of Wisconsin–Madison, jointly appointed in the Department of Cell and Regenerative Biology and the Department of Chemistry. Her research integrates chemistry, biology, and medicine, focusing on advanced mass spectrometry-based proteomic and metabolomic technologies to address cardiovascular diseases. Education: B.S., Peking University (1997) Ph.D., Cornell University (2002) Ying Ge's work centers on developing ultra high-resolution mass spectrometry platforms for top-down proteomics and metabolomics, applied to systems biology studies of heart failure and regenerative medicine. Key projects include myofilament protein modification mapping, stem cell therapy evaluation, and biomarker discovery for cardiac conditions. The 15 most recent articles highlight her lab's methodological innovations (e.g., photocleavable surfactants, native mass spectrometry) and biological discoveries in AMPK structural heterogeneity, RBM20-mediated cardiotoxicity, and sarcomere-metabolism cross-talk during regeneration. These publications span proteomics, metabolomics, structural biology, and clinical applications.
Matthew R. Jones is an Associate Professor in the Department of Chemistry at Rice University and holds the Gene and Norman Hackerman Junior Chair and Norman Hackerman-Welch Young Investigator titles. He joined Rice in 2017 after postdoctoral research at UC Berkeley under Paul Alivisatos and a PhD at Northwestern University under Chad Mirkin. His research focuses on systems-level nanoparticle assembly, plasmonics, and metamaterials, with applications in energy storage and biomedicine. Jones has pioneered techniques like 4D-STEM for catalytic nanoparticles and developed adaptive materials via strain-controlled synthesis. Education: B.S. in Materials Science and Biomedical Engineering (Carnegie Mellon University), Ph.D. in Chemistry (Northwestern University as an NSF Fellow). Key awards include the Packard Fellowship (2018) and NSF CAREER Award (2022). His lab hosts over 20 graduate students and postdocs, with notable advisees including Bukky, Zhihua Cheng, and Saxton. Research emphasizes interdisciplinary approaches: combining in-situ microscopy, ligand engineering, and computational modeling to control nanoparticle behavior. Recent studies include strain-preserved nanocatalysts (2024) and chiral superlattices (2024). Collaborations span Rice’s Center for Nanoscale Imaging Sciences and the Electrochemical Society. Lab: Jones Research Group Grants: NSF CAREER, Packard Fellowship, Rice Seed Award Publications: Over 50 peer-reviewed articles, including Science Advances (2024) and Nature Communications (2023)
Christopher Parlett is a **Lecturer** in the **CE - Academic & Research** division at the University of Manchester, concurrently serving as a **University of Manchester-Diamond Light Source Research Fellow in Catalysis**. He leads research at the **University of Manchester at Harwell group**, focusing on heterogeneous catalytic systems and operando X-ray spectroscopy to study catalytic active sites. His work emphasizes sustainable chemical conversions, including selective oxidations and biomass upgrading, alongside functional nanomaterials for applications in gas storage and healthcare. **Education**: PhD in Chemistry from Cardiff University (under Professors Adam F. Lee and Karen Wilson), MSc in Green Chemistry from the University of York, and BSc in Chemistry from Anglia Ruskin University. **Research Themes**: Catalyst design, metal-support interactions, porous oxide materials, and operando X-ray absorption spectroscopy. His projects aim to develop nano-engineered materials for industrial applications, replacing costly and environmentally harmful reagents. **Key Activities**: Organized the 25th Annual Green Chemistry & Engineering Conference (2021), co-edits the *Emergent Materials* journal, and chairs the SCI Early Careers Materials Committee. Active in professional organizations like the Institution of Chemical Engineers. **Grants & Projects**: Principal Investigator for the ongoing *UoMaH: The University of Manchester at Harwell* project (since 2018), exploring nanoparticles, catalytic reactions, and advanced materials. **Labs/Teams**: Part of the Manchester at Harwell research hub, collaborating on synchrotron-based studies and catalytic material development.
Professor Roland J. Pieters is a distinguished academic at Utrecht University's Faculty of Science, where he serves as a full Professor in the Department of Chemical Biology and Drug Discovery. With over two decades of experience at the institution, he has progressed from Assistant Professor (1998) to Associate Professor (2005) and ultimately to Full Professor (2010-present). His research group is internationally recognized for groundbreaking work at the intersection of carbohydrate chemistry, chemical biology, and drug discovery, with particular emphasis on developing novel therapeutic approaches against bacterial infections and pathogenic mechanisms. Full Professor, Utrecht University (2010-present) Associate Professor, Utrecht University (2005-2010) Assistant Professor, Utrecht University (1998-2005) NWO Talent Post-doctoral Fellow, ETH-Zürich (1995-1996) Postdoctoral Researcher, University of Groningen (1996-1998) Professor Pieters earned his M.Sc. in Organic Chemistry from the University of Groningen in 1990, where he worked with Professor Ben Feringa, and completed his Ph.D. at MIT in 1995 under the supervision of Professor Julius Rebek Jr. His doctoral research focused on molecular recognition and template effects in bisubstrate systems, establishing the foundation for his lifelong interest in molecular interactions. Professor Pieters' research primarily centers on glycodrugs and the strategic interference with protein-carbohydrate interactions using multivalent systems of varying architectures. His laboratory has made significant contributions to understanding how rigid spacers in multivalent ligands can dramatically enhance binding affinity to target proteins, with applications against viral and bacterial adhesion proteins, toxins, galectins, and glycosidases. A particular focus has been on developing inhibitors for Pseudomonas aeruginosa lectin LecA, cholera toxin, influenza virus hemagglutinin, and more recently, SARS-CoV-2 spike protein interactions with host cell receptors. His group also pioneered the use of glyco- and peptide-microarrays for high-throughput screening of carbohydrate-protein interactions and drug discovery, particularly in the area of O-GlcNAcylation research. The publication record of Professor Pieters demonstrates consistent innovation in the field of multivalent carbohydrate-based therapeutics. His recent work (2020-2024) shows a strategic expansion into viral pathogenesis (particularly influenza and SARS-CoV-2), immune modulation through glycan recognition, and novel approaches to vaccine development. A notable trend is the increasing sophistication of multivalent architectures, moving from simple divalent systems to tetra- and hexavalent ligands with precisely engineered spatial arrangements. His research bridges fundamental chemical principles with practical therapeutic applications, maintaining strong connections to pharmaceutical development while advancing basic science understanding of carbohydrate-mediated biological processes. Professor Pieters' scientific achievements have been recognized with prestigious awards including a Fellowship from the Royal Netherlands Academy of Arts and Sciences (KNAW) in 1999 and a VICI personal grant from the Netherlands Organisation for Scientific Research (NWO) in 2008. These competitive awards reflect the significance and innovation of his research program. He has also served on editorial advisory boards, notably as Section Editor-in-Chief for Chemical Biology in the journal Molecules (2018-2022), contributing to the scholarly community through peer review and academic leadership. Fellowship of Royal Netherlands Academy of Sciences (KNAW), 1999 VICI, personal grant, NWO, 2008 Section Editor-in-Chief Chemical Biology for Molecules (2018-2022) Throughout his career, Professor Pieters has coordinated significant research projects including the EU project POLYCARB and secured competitive funding that has sustained his innovative research program. His laboratory has fostered numerous collaborations across Europe and internationally, creating a vibrant research environment that has trained many scientists now working in academia and industry. His research on multivalent carbohydrate systems represents a sustained intellectual contribution to chemical biology with direct relevance to developing new anti-infective strategies and therapeutic approaches. Professor Pieters leads an active research group within Utrecht University's Department of Chemical Biology and Drug Discovery, situated in the David de Wied Building. His laboratory maintains strong connections with other research groups both within Utrecht University and internationally, particularly in the fields of glycobiology, infectious diseases, and drug discovery. The research environment he has cultivated emphasizes interdisciplinary approaches, combining synthetic chemistry, biophysical analysis, and biological testing to address fundamental questions in carbohydrate-mediated biological processes with therapeutic applications.
Associate Professor LAM Yulin is affiliated with the National University of Singapore (NUS), specializing in bioorganic and medicinal chemistry with a focus on green synthesis methodologies. His research interests include developing anti-cancer, anti-inflammatory, and neurological agents, alongside creating recyclable catalysts for sustainable organic transformations. He holds a Ph.D. (1992) and B.Sc. (1987) from NUS, with prior research fellowships at the Institute of Molecular and Cell Biology (1994–1996) and The Scripps Research Institute (1992–1994). Teaching contributions include courses such as CM2122 Organic Chemistry, CM3225 Biomolecules, and CM5224 Emerging Concepts in Drug Discovery. His research highlights include synthesizing chondroitin sulfate analogs for molecular recognition via surface-enhanced Raman scattering (SERS) and developing fluorous boronic acid catalysts for amide bond formation under eco-friendly conditions. Research focuses on glycosaminoglycan structure-function relationships, novel mycobacterial inhibitors, and autophagy-inducing agents. His work bridges organic synthesis with biomedical applications, emphasizing sustainability and translational potential.
Andrew Sutherland is Professor of Organic Chemistry at the University of Glasgow , School of Chemistry. His research integrates synthetic organic chemistry with molecular imaging, focusing on PET/SPECT tracer development, fluorescent amino acid probes, and transition-metal catalysis for rapid scaffold assembly. Education: Not explicitly listed in the provided text. Research Interests: Molecular imaging of neurological diseases and cancer using PET/SPECT tracers Development of fluorescent amino acid probes for cell imaging Transition-metal-catalyzed transformations (Fe, Cu, Pd, Ni) One-pot multi-reaction processes for drug-like scaffolds and natural products Publication Trends: His 2024–2025 work emphasizes fluorogenic amino acids, radiohalogenation for PET imaging, and iron/copper-catalyzed C–H functionalization. Earlier work includes natural product synthesis and mechanistic studies on halodeboronation. Scientific Awards: None listed in the provided text. Grants & Collaborations: Extensive collaborations with imaging scientists (e.g., Sally Pimlott, Adriana Tavares) and synthetic chemists, evidenced by multi-author papers and joint PET ligand development. Research Group: Leads the Sutherland group , housed in the Joseph Black Building (C5-06), with active projects in chemical biology and organic synthesis.
Michael Organ is a Full Professor at the University of Ottawa's Department of Chemistry and Biomolecular Sciences, affiliated with the Faculty of Science. He also serves as Director of the Centre for Research and Innovation in Catalysis. His research focuses on catalysis, flow chemistry, and medicinal chemistry, emphasizing sustainable and efficient synthesis methods. Organ has held adjunct roles at the University of Toronto and has extensive industry collaborations, including with GlaxoSmithKline and Abbvie. Education: PhD (University of Guelph, 1992), MSc (University of Guelph, 1988), Hons. BSc (University of Guelph, 1986). Research Interests: Catalysis, microwave-assisted continuous synthesis, reactive intermediates in flow systems, and drug discovery methodologies. His work bridges organic chemistry with engineering, developing scalable and green processes. Publications & Impact: Over 200 publications, including seminal works in Journal of the American Chemical Society and Chemistry – A European Journal . Key contributions include the Pd-PEPPSI-IPent catalyst and the MACOS flow chemistry platform. Awards: NSERC John C. Polanyi Award (2018), Encyclopedia of Reagents Best Reagent Award (2017), Raymond Lemieux Award (2016). Recognized internationally for catalytic innovations. Grants & Funding: Over $45M in research funding, including NSERC Discovery Grants and industry partnerships. Notable projects include CFI JELF grants for sustainable manufacturing and pandemic-related flow chemistry for SARS-CoV-2 diagnostics. Labs & Teams: Leads the Organ Group, collaborating with chemical engineers and industry partners. Specializes in reactor design, catalyst development, and continuous processing systems.
Dr Marina Uzelac is a Royal Society University Research Fellow in the Department of Chemistry at the University of Bath, affiliated with the Institute of Sustainability and Climate Change. She is actively leading two research projects funded by The Royal Society focused on manganese catalysis and is accepting doctoral students. Education: PhD in Chemistry, University of Strathclyde (awarded 2016) MSc in Chemistry, University of Zagreb (2011) BSc in Chemistry, University of Zagreb (2009) Her research lies at the intersection of inorganic and synthetic chemistry, with a focus on cooperative reactivity of rarely employed metals, particularly manganese and alkali metals. She investigates the use of manganates in catalytic transformations, electrophilic borylation strategies, and the development of sustainable synthetic methodologies. Her work often involves N-heterocyclic carbenes and explores structural diversity in metal complexes. The recent publications highlight a strong trend in organometallic synthesis, C-H functionalization, and the design of novel borylation methods with applications in materials science, particularly BN-doped helicenes. Her work bridges fundamental inorganic chemistry with practical synthetic applications. Scientific Awards: Royal Society University Research Fellow Dr Uzelac is the Principal Investigator on two active grants from The Royal Society: 'Mn(II): A Janus Face for Catalysis' and its enhanced research expenses counterpart, both running from 2022 to 2027. These grants support her independent research program in sustainable catalysis. While no formal advisees are listed, she is accepting doctoral students, indicating an emerging supervisory role. She is actively involved in research networks and collaborations across Europe, particularly in the areas of main group and transition metal chemistry. Her work is disseminated through high-impact journals and has garnered attention in academic and social media circles.
